Compare Bundamedik Tbk (BMHS) vs Tripar Multivision Plus Tbk. (RAAM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bundamedik Tbk vs Tripar Multivision Plus Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Tripar Multivision Plus Tbk. trades at Rp199 (market cap 1.39T, 201.9K 24h volume). The key difference: Bundamedik Tbk and Tripar Multivision Plus Tbk. are close in size by market cap, and Bundamedik Tbk is more actively traded (536.7K versus 201.9K). Which is the better fit depends on your goals.
| BMHS | RAAM | |
|---|---|---|
Market Cap | 1.51T | 1.39T |
Volume | 536.7K | 201.9K |
Lot | 5.37K | 2.02K |
Turnover | 93.41M | 40.78M |
Average Price | 174.05 | 201.96 |
Value | 93.41M | 40.78M |
Indicative Equilibrium Price | 176 | 199 |
Indicative Equilibrium Volume | 100 | 6 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bundamedik Tbk
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →About Tripar Multivision Plus Tbk.
PT Tripar Multivision Plus Tbk (“the Company”) was establishedbased on Deed of Establishment of Limited Liability Company No. 17 dated 6 December 1990 drawn up before Adlan Yulizar, S.H., notary in Jakarta.
Read more on RAAM →
